MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

The board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria approved a new funding model, which avoided imposing caps for countries applying for funding. In November, the board will decide on further details pertaining to the new model. 

More >

A new MSF report warns that cancellation of global fund grants will have devastating effect in Myanmar.

More >

As the Global Fund to Fight AIDS, Tuberculosis, and Malaria marks its tenth anniversary, people living with HIV/AIDS and those delivering treatment took to the streets in response to drastic funding shortfalls.

More >

The vast majority of people living with the AIDS virus in the Democratic Republic of Congo are deprived of lifesaving treatment.

More >

MSF International President Dr. Unni Karunakara discusses the Global Fund to Fight AIDS, TB, and Malaria's decision not to accept grant applications this year to support treatment programs due to a catastrophic drop in donor funding. 

More >

MSF responds to the unprecedented decision taken to cancel a funding round of the Global Fund to Fight AIDS, TB and Malaria.

More >

Without appropriate funding, the opportunity to reap the benefits of new science showing that HIV treatment both saves lives and helps prevent new infections could be lost.

More >

The financial transaction tax proposed by France and Germany could help save millions of lives if a percentage were allocated to global health, MSF said today.

More >

Several pharmaceutical companies have abandoned HIV drug discount programs in middle-income countries, according to an HIV drug price report released by MSF.

More >

NEW DELHI/BRUSSELS, June 22, 2011–At the United Nations High Level Meeting on HIV and AIDS in early June, India announced that it will not accept data exclusivity, a provision harmful to access to affordable medicines, as part of a free trade agreement (FTA) currently being negotiated with the European Union (EU).

More >

Pages